Atrial Fibrillation Cryoablation at the Gates Vascular Institute What You Should Know Pre-Procedure Testing Computed Tomography
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Computing in Cardiology
COMPUTING IN CARDIOLOGY September 13-16, 2020 Rimini, Italy Table of Contents Sponsors 3 Welcome to CinC@Rimini in 2020! 5 Board of Directors 7 Local Organizing Committee 8 Letter from the President 9 Welcome to Brno for CinC 2021 10 Maps 11 General Map of Rimini 11 Transportation, Hotels and Practical Information 14 Transportation 14 By air 14 By car 14 By train 14 Local Transportation in Rimini 15 By bus 15 By bike 15 Practical Information 16 Climate 16 Money/currency 16 Emergency phone numbers 16 Electric standards 16 Language 17 Time Zones 17 Mobile Phones 17 Safety and Security 17 COVID-19 emergency – Main general rules in Emilia - Romagna 17 COVID-19 emergency – Safety rules and procedures at Palacongressi 18 Internet Access 19 Computing in Cardiology 2020 1 Meals 20 Accompanying Persons (Guests) 20 Conference Information 21 General Information 21 Sunday Symposium 21 Programme outline 21 Conference site 22 Monday Social Program 23 Activist program 23 Passivist program 24 For Authors and Speakers 25 Oral presentations 25 IN PERSON oral presentations 25 REMOTE oral presentations 26 Q&A during oral presentations 26 Poster presentations 26 IN PERSON poster session 26 REMOTE poster session 27 Rosanna Degani Young Investigator Award 28 Clinical Needs Translational (CTA) Award 28 PhysioNet/Computing in Cardiology Challenge 2020 28 Maastricht Simulation Award (MSA) 29 Deadlines 29 Manuscripts 29 Scientific Program Details 31 Program Overview 2 Computing in Cardiology 2020 Sponsors Computing in Cardiology 2020 is supported by several institutions, companies and academic partnerships. The Local Organizing Committee would like to thank the following partners: Computing in Cardiology 2020 3 4 Computing in Cardiology 2020 Welcome to CinC@Rimini in 2020! Dear Colleagues and Friends, On behalf of the Local Organizing Committee, we warmly welcome you to Computing in Cardiology 2020. -
Clinical Guideline Experimental Or Investigational Services
Clinical Guideline Guideline Number: CG012, Ver. 6 Experimental or Investigational Services Disclaimer Clinical guidelines are developed and adopted to establish evidence-based clinical criteria for utilization management decisions. Oscar may delegate utilization management decisions of certain services to third-party delegates, who may develop and adopt their own clinical criteria. Clinical guidelines are applicable to certain plans. Clinical guidelines are applicable to members enrolled in Medicare Advantage plans only if there are no criteria established for the specified service in a Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) or local coverage determination (LCD) on the date of a prior authorization request. Services are subject to the terms, conditions, limitations of a member’s policy and applicable state and federal law. Please reference the member’s policy documents (e.g., Certificate/Evidence of Coverage, Schedule of Benefits) or contact Oscar at 855-672-2755 to confirm coverage and benefit conditions. Summary The services referenced in this Clinical Guideline are considered experimental or investigational and are therefore not covered by Oscar. The services referenced in this Clinical Guideline may not be all- inclusive. Specific benefit plan documents (e.g., Certificate of Coverage, Schedule of Benefits) and federal or state mandated health benefits and laws take precedence over this Clinical Guideline. A service considered experimental or investigational when its safety and efficacy has been established. They may have outcomes that are inferior to standard medical treatment, for which long-term clinical utility has been established. To determine whether a service, device, treatment or procedure has proven safety and efficacy, the available reliable evidence is reviewed, which may include but is not limited to (listed in order of decreasing reliability): 1. -
Left Anterior Descending Coronary Artery Dissection During Ventricular Tachycardia Ablation – Case Report
CASE REPORTS Left anterior descending coronary artery dissection during ventricular tachycardia ablation – case report KRESIMIR KORDIC, SIME MANOLA, IVAN ZELJKOVIC, IVICA BENKO, NIKOLA PAVLOVIC University Hospital Center Sisters of Charity, Department of Cardiology, Zagreb, Croatia Fascicular left ventricular tachycardia (VT) is the second most frequent idiopathic left VT in the setting of a structurally normal heart. Catheter ablation is curative in most patients with low complication rates. We report a case of ostial left anterior descending coronary artery (LAD) occlusion during fascicular ventricular tachycardia ablation. Dissection was the most likely cause of LAD obstruction. To the authors’ best knowledge, this is the first case reporting selective LAD dissection during electrophysiology study with no left main coronary artery (LMCA) affection. Key words: ventricular tachycardia, electrophysiology, radiofrequency catheter ablation, ST elevation myocardial infarction, percutaneous coronary intervention. INTRODUCTION An electrocardiogram following cardioversion showed normal sinus rhythm, without preexcitation Fascicular left ventricular tachycardia (VT) is or conduction abnormalities. There was no structural the second most frequent idiopathic left VT, after heart disease found on transthoracic echocardio- left ventricular outflow tract VT, occurring in the graphy. setting of a structurally normal heart [1]. An electrophysiology study was performed According to current ESC guidelines [2], using right femoral approach. During the tachy- catheter ablation is curative in most patients with cardia, His was activated after the ventricular VT without overt structural heart disease, with low activation and tachycardia could be entrained from complication rates (around 3%) [3]. Complications atrium and the ventricle. Based on these findings, include access site vascular complications, thrombo- the diagnosis of fascicular ventricular tachycardia embolism, atrioventricular block, myocardial per- was established. -
Late Presentation of Constrictive Pericarditis After Limited Epicardial Ablation for Inappropriate Sinus Tachycardia
Late presentation of constrictive pericarditis after limited epicardial ablation for inappropriate sinus tachycardia Adam Oesterle, MD,* Amita Singh, MD,* Husam Balkhy, MD,* Aliya N. Husain, MD,† Deborah Moyer, APN,* Roderick Tung, MD, FHRS,* Hemal M. Nayak, MD, FHRS* From the *Center for Arrhythmia Care, Heart and Vascular Center, The University of Chicago Medicine, Chicago, Illinois, and †Department of Pathology, The University of Chicago Medicine, Chicago, Illinois. Introduction Biosense-Webster Thermocool SF catheter (Diamond Bar, CA) was delivered in the endocardium. The ablation catheter The number of radiofrequency catheter ablation (RFA) and the angioplasty balloon were both removed and the procedures performed in the epicardial space is increasing.1 ablation catheter was inserted into the epicardial space Major acute complications (primarily pericardial bleeding) through the deflectable sheath, and 5 focal lesions were and delayed complications have been reported in 5% and 2% – delivered in the epicardium overlying the sinus node. At the of cases, respectively.2 4 To the best of our knowledge, a end of the procedure his heart rate decreased from 140 to 70 single case of constrictive pericarditis after multiple epicar- beats per minute. Kenalog (1 mg/kg) was injected into the dial ablations for ventricular tachycardia has been reported.5 pericardial space and the epicardial sheath was removed We describe a late presentation of constrictive pericarditis immediately after the procedure. The fluid was serous, that occurred after a single percutaneous epicardial without any evidence of bleeding, throughout the case. procedure with limited ablation for inappropriate sinus Twelve hours after the procedure, the patient developed tachycardia. pleuritic chest pain, treated with indomethacin, colchicine, and his home dose of aspirin 81 mg daily. -
Electrophysiology with Artificial Intelligence Context and Challenge
Envisioning Cardiac Electrophysiology with Artificial Intelligence Context and Challenge An estimated 17 million people die of cardiovascular As technology advances, various industries are adopting diseases (CVDs) every year worldwide. CVD covers technologies such as digital transformation, internet of hypertension, sudden cardiac arrest, arrhythmia/rhythm things (IoT), artificial intelligence (AI), nanotechnology, disturbance, stroke, peripheral artery disease, and many and so on within their product/service portfolio and the more. Arrhythmias constitute a major problem, wherein the medical device industry is no exception. the heart beats either too quickly or too slowly or with an irregular pattern [1]. This indicates the malfunctioning of The focus of this paper is to discuss software-based the hearth’s electrical system. Clinical symptoms including solutions incorporating AI within EP systems that can shortness of breath, dizziness, sudden weakness, fluttering improve overall system performance, improve the in the chest, lightheadedness, and fainting, are indications therapeutic outcomes, reduce procedural time, and assist for malfunctioning of the heart. the electrophysiologist during the procedure. An electrophysiology (EP) study is a test to assess a person’s cardiac electrical activity. It helps the electrophysiologist to diagnose and determine the precise location and nature of arryhthmias. The test is performed by inserting catheters and wired electrodes to measure electrical activity through blood vessels that enter the heart. The two main goals of a cardiac EP study are (1) to accurately diagnosis the conduction-disturbance mechanism and (2) to determine the best line of treatment for the conduction-disturbances. Treatment following a cardiac EP study could range from ablation therapy to pharmacologic to device to surgical intervention based on the nature of the findings. -
About Electrophysiology Study of the Heart
About Electrophysiology Study of the Heart What is an Electrophysiology Study? An ElectroPhysiology (EP) Study is a test that looks at the electrical system of your heart. An EP Study will show if you have a heart rhythm problem and what is causing the problem. Heart rhythm problems are known as arrhythmias. Why is an EP Study done? An EP Study is done when you have problems such as fainting, dizziness, heart palpitations or an abnormal heart beat. How does the heart work? To understand this procedure, you need to know how the heart’s electrical system works. The sinoatrial node (SA node) is a natural pacemaker. It starts the electrical signal that travels across the upper 2 chambers or atria of the heart to the atrioventricular node (AV node). The AV node transfers the electrical signal from the upper part of the heart to the lower 2 pumping chambers or ventricles. The bundle branches are specialized tissues that help send electrical impulses through the ventricles. This makes a normal heart beat called normal sinus rhythm. 01-77-0623-0 (Rev 03/2016) Page 1 of 4 What causes heart rhythm problems? Problems happen when the heart beats too fast or too slow. Some people are born with heart rhythm problems. Problems may also be caused by aging or heart disease. There are many different kinds of arrhythmias. Problems occur when the heart beats too fast or too slow. When this happens you may feel: dizzy faint short of breath very tired palpitations (pounding in your chest) The treatment for heart rhythm problems may include one or more of the following: medication a pacemaker a defibrillator ablation Who will do the EP Study? A doctor who specializes in ElectroPhysiology (EP) will do the procedure. -
Coronary Sinus Cryoablation of Ventricular Tachycardia After Failed Radiofrequency Ablation
www.symbiosisonline.org Symbiosis www.symbiosisonlinepublishing.com Case Report Journal of Clinical Trials in Cardiology Open Access Coronary Sinus Cryoablation of Ventricular Tachycardia after Failed Radiofrequency Ablation Jiménez-Fernández M*, Macías- Ruiz R, Álvarez-López M, and Tercedor- Sánchez L Virgen de las Nieves University Hospital, Granada, Spain Received: March 11, 2014; Accepted: September 10, 2014; Published: September 25, 2014 *Corresponding author: Miriam Jiménez-Fernández, Virgen de las Nieves University Hospital, Granada, Spain, E-mail: [email protected] Abstract We present a case of Great Cardiac Vein (GCV) cryoablation in order to suppress idiopathic epicardial Ventricular Tachycardia (VT) after failed Radiofrequency (RF) ablation via the epicardium and GCV. RF ablation is the technique of choice for the treatment of Ventricular Arrhythmias (VA). However, this procedure has its limitations when delivered inside the distal cardiac veins. Cryoablation is a good alternative in patients where RF cannot be used because of risk of high impedance. Keywords: Percutaneous epicardial ablation; Ventricular tachycardia; Radiofrequency; Catheter ablation; Cryoablation; Coronary sinus; High impedance; Cryoenergy; Great cardiac vein; Mapping; Electroanatomic mapping system; 12-lead surface electrocardiogram Case Report tachycardia, but the delivery of RF had to be interrupted with a maximal energy of 15 W, as the impedance rise exceeded the A 56-year-old female patient presented in emergency room referring shortness of breath and chest pain. ECG showed we decided to change to a 6 mm tip cryoablation catheter that was sustained monomorphic VT at 160 beats per minute with right ablesafety to limit reach (>300 the programmed Ω) (Figure 1C). temperature In order to of solve -80°C this suppressing problem, bundle branch block and right inferior axis morphology (Figure the VT with no further recurrences. -
2018 EP Reimbursement and Coding Guide Physicians and Facilities Resources to Assist You with the Reimbursement Process!
2018 EP Reimbursement and Coding Guide Physicians and Facilities Resources to assist you with the Reimbursement Process! Reimbursement and Coding and Reimbursement Electrophysiology EP Procedure Documentation Coding Guide Frequently Asked Questions Coding Checklist Best Practices Online HCPCS C-Code Finder Coding & Reimbursement Webinars Email your Coding Questions www.biosensewebster.com/reimbursement Electrophysiology Diagnostic, Ablation, and Intracardiac Echocardiography Guided Transcatheter Procedures This guide has been developed to assist you in obtaining physician payment and hospital reimbursement for: • Electrophysiology (EP) diagnostic and ablation procedures • The acquisition of radiological images • EP and Cardiology procedures that may utilize intracardiac echocardiography (ICE) These procedures may be a covered service if they meet all of the requirements established by Medicare and private payers. It is essential that each claim be coded properly and supported with appropriate documentation in the medical record. TABLE OF CONTENTS PHYSICIAN SERVICES 4-6 CPT® Codes OUTPATIENT FACILITY SERVICES 7 Ambulatory Payment Classifications (APCs) INPATIENT FACILITY SERVICES 8 Medicare Severity Diagnosis Related Groups (MS-DRGs) PROCEDURE CODES 9-10 ICD-10-CM Procedure Codes DIAGNOSIS CODES 11-13 ICD-10-CM Diagnosis Codes HCPCS CODES FOR BIOSENSE WEBSTER, INC. PRODUCTS 14-15 NOTES 16 DISCLAIMER The information contained in this guide is provided to assist you in understanding the reimbursement process. It is intended to assist providers in accurately obtaining reimbursement for health care services. It is not intended to increase or maximize reimbursement by any payer. We strongly suggest that you consult your payer organization with regard to local reimbursement policies. The information contained in this document is provided for information purposes only and represents no statement, promise or guarantee by Biosense Webster, Inc. -
Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center
medicina Article Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center Stefano Cernic 1,* , Cristina Marrocchio 2 , Riccardo Ciabattoni 2, Ilaria Fiorese 2, Fulvio Stacul 3, Fabiola Giudici 4,5 , Michele Rizzo 6 and Maria Assunta Cova 2 1 Department of Radiology, ASUGI, Ospedale di Cattinara, 30149 Trieste, Italy 2 Department of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, Italy; [email protected] (C.M.); [email protected] (R.C.); fi[email protected] (I.F.); [email protected] (M.A.C.) 3 Department of Radiology, ASUGI, Ospedale Maggiore, 30125 Trieste, Italy; [email protected] 4 Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35122 Padova, Italy; [email protected] 5 Unit of Biostatistic, Department of Medical, Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy 6 Department of Urology, University, ASUGI, Ospedale di Cattinara, 30149 Trieste, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-040-399-4372; Fax: +39-040-399-4350 Abstract: Background and objectives: Cryoablation is emerging as a safe and effective therapeutic option for treating renal cell carcinoma. This study analyzed the safety and long-term oncological outcomes of cryoablation in our center. Materials and methods: Patients who underwent computed Citation: Cernic, S.; Marrocchio, C.; tomography (CT)-guided percutaneous cryoablation between February 2011 and June 2020 for one Ciabattoni, R.; Fiorese, I.; Stacul, F.; or more clinically localized renal tumors were identified. Technical success and treatment efficacy Giudici, F.; Rizzo, M.; Cova, M.A. -
Electrophysiology Study
Electrophysiology (EP) Study Highly trained specialists perform EP studies in a specially designed EP lab outfitted with advanced technology and equipment. Why an EP study? The Value of an EP Study While electrocardiograms (ECGs An electrophysiology, or EP, study or EKGs) are important tests of the provides information that is key to heart’s electrical system, they diagnosing and treating arrhythmias. provide only a brief snapshot of Although it is more invasive than an the heart’s electrical activity. electrocardiogram (ECG) or echocar - Arrhythmias can be unpredictable diogram, and involves provoking and intermittent, which makes it arrhythmias, the test produces data unlikely that an electrocardiogram that makes it possible to : will capture the underlying electri - Normally, electricity flows through - cal pathway problem. Even tests • Diagnose the source of arrhythmia out the heart in a regular, meas - that stretch over longer time periods , symptoms such as Holter monitoring, may not ured pattern. This electrical system • Evaluate the effectiveness of capture an event. brings about coordinated heart certain medications in controlling muscle contractions. A problem During an EP study, a specially the heart rhythm disorder anywhere along the electrical trained cardiac specialist may pro - • Predict the risk of a future cardiac pathway causes an arrhythmia, voke arrhythmia events and collect event, such as Sudden Cardiac or heart rhythm disturbance. By data about the flow of electricity Death accurately diagnosing the precise during actual events. As a result, cause of an arrhythmia, it is possi - • Assess the need for an implantable EP studies can diagnose the ble to select the best possible device (a pacemaker or ICD) or cause and precise location of the treatment. -
Cardiac Ablation: Types and Outcomes
CARDIAC ABLATION: TYPES AND OUTCOMES CARDIOVERSION AND ABLATION JASSIN M. JOURIA Dr. Jassin M. Jouria is a practicing Emergency Medicine physician, professor of academic medicine, and medical author. He graduated from Ross University School of Medicine and has completed his clinical clerkship training in various teaching hospitals throughout New York, including King’s County Hospital Center and Brookdale Medical Center, among others. Dr. Jouria has passed all USMLE medical board exams, and has served as a test prep tutor and instructor for Kaplan. He has developed several medical courses and curricula for a variety of educational institutions. Dr. Jouria has also served on multiple levels in the academic field including faculty member and Department Chair. Dr. Jouria continues to serve as a Subject Matter Expert for several continuing education organizations covering multiple basic medical sciences. He has also developed several continuing medical education courses covering various topics in clinical medicine. Recently, Dr. Jouria has been contracted by the University of Miami/Jackson Memorial Hospital’s Department of Surgery to develop an e-module training series for trauma patient management. Dr. Jouria is currently authoring an academic textbook on Human Anatomy & Physiology. ABSTRACT Atrial arrhythmias are serious disorders that can cause an irregular and/or rapid heartbeat, which can lead to serious clinical sequelae. Atrial fibrillation is an example of an atrial arrhythmia that can lead to blood clots, stroke, or heart failure. Electrical cardioversion and ablation are two procedures that can minimize these risks and treat atrial arrhythmia. Each of these treatments have risks and neither offers a complete success rate, but they can be very effective in providing greater quality of life, and extending the life expectancy of patients. -
Cardiac Output 98
Chapter Cardiac Output 98 INTRODUCTION DEFINITIONS AND NORMAL VALUES STROKE VOLUME MINUTE VOLUME CARDIAC INDEX EJECTION FRACTION CARDIAC RESERVE VARIATIONS IN CARDIAC OUTPUT PHYSIOLOGICAL VARIATIONS PATHOLOGICAL VARIATIONS DISTRIBUTION OF CARDIAC OUTPUT FACTORS MAINTAINING CARDIAC OUTPUT VENOUS RETURN FORCE OF CONTRACTION HEART RATE PERIPHERAL RESISTANCE MEASUREMENT OF CARDIAC OUTPUT DIRECT METHODS INDIRECT METHODS CARDIAC CATHETERIZATION DEFINITION CONDITIONS WHEN CARDIAC CATHETERIZATION IS PERFORMED PROCEDURE USES OF CARDIAC CATHETERIZATION INTRODUCTION 1. Stroke volume 2. Minute volume Cardiac output is the amount of blood pumped from 3. Cardiac index. each ventricle. Usually, it refers to left ventricular output However, in routine clinical practice, cardiac output through aorta. Cardiac output is the most important refers to minute volume. factor in cardiovascular system, because rate of blood flow through different parts of the body depends upon STROKE VOLUME cardiac output. Stroke volume is the amount of blood pumped out by each ventricle during each beat. DEFINITIONS AND NORMAL VALUES Normal value: 70 mL (60 to 80 mL) when the heart rate Usually, cardiac output is expressed in three ways: is normal (72/minute). Chapter 98 t Cardiac Output 573 MINUTE VOLUME 5. Environmental temperature: Moderate change in temperature does not affect cardiac output. Increase Minute volume is the amount of blood pumped out by in temperature above 30°C raises cardiac output. each ventricle in one minute. It is the product of stroke 6. Emotional conditions: Anxiety, apprehension and volume and heart rate: excitement increases cardiac output about 50% to Minute volume = Stroke volume × Heart rate 100% through the release of catecholamines, which Normal value: 5 L/ventricle/minute.